Please use this identifier to cite or link to this item:
Title: Cytotoxic triosmium carbonyl clusters : a structure-activity relationship study
Authors: Top, Siden
Vessières, Anne
Leong, Weng Kee
Lee, Shirley Hui Zhi
Keywords: DRNTU::Science::Biological sciences::Biochemistry
Issue Date: 2013
Source: Lee, H. Z. S., Leong, W. K., Top, S., & Vessières, A. (2014). Cytotoxic Triosmium Carbonyl Clusters: A Structure-Activity Relationship Study. ChemMedChem, 9(7), 1453–1457.
Series/Report no.: ChemMedChem
Abstract: A structure–activity relationship (SAR) study of the triosmium carbonyl cluster Os3(CO)10(NCCH3)2 was carried out with a series of clusters of the general formula Os3(CO)12−nLn, cationic osmium clusters and a hemi-labile maltolato-Os cluster. The SAR results showed that good solubility in DMSO and at least one vacant site are required for cytotoxicity. In vitro evaluation of these new compounds showed that some are selectively active against estrogen receptor (ER)-independent MDA-MB-231 breast cancer cell lines relative to ER-dependent MCF-7 breast cancer cells, suggesting that the compounds have a different biological target specific to MDA-MB-231 cells. In particular, the maltolato cluster exhibits strong antiproliferative activity, with an IC50 value of 3 μM after only 24 h incubation. Additionally, biochemical assays conducted with the cationic cluster show that it induces apoptosis, although a biological target has not yet been identified. Further research to establish the molecular targets of these compounds and to develop improved organometallic clusters as potential breast cancer therapeutics is underway.
ISSN: 1860-7179
DOI: 10.1002/cmdc.201300394
Rights: © 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Fulltext Permission: none
Fulltext Availability: No Fulltext
Appears in Collections:SPMS Journal Articles

Citations 20

Updated on Mar 23, 2023

Web of ScienceTM
Citations 20

Updated on Mar 27, 2023

Page view(s) 50

Updated on Mar 29, 2023

Google ScholarTM




Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.